Search All News
The Substance Abuse and Mental Health Services Administration has awarded $32 million to the American Academy of Addiction Psychiatry to address opioid use disorders and stimulant use disorders.
Columbia researchers have found a potential neurobiological mechanism for hallucinations and delusions that fits within the hierarchical model of psychosis and can explain their clinical presentation
Dr. J. John Mann joins Dr. Lloyd Sederer on Medscape to discuss the effectiveness of Ketamine as a treatment for depression.
"For children not physically attending school, it is important to build and maintain other meaningful social opportunities," says Dr. Anthony Puliafico.
Source:StatSeptember 18, 2020
“I think intuitively all the people in this field know that the future of mental health is going to involve digital health care in some way, shape, or form,” said Dr. Ravi Shah.
- September 4, 2020
“I know there was a dip in experimental productivity initially, but in the last six weeks, I think we’re almost back to normal,” says Dr. David Sulzer.
- August 14, 2020
A study involving older adults with pre-existing major depressive disorder found no increase in depression and anxiety during the COVID-19 pandemic.
Source:FilterMay 20, 2020
Columbia researchers examined longitudinal studies of how prenatal cannabis use affected children’s cognitive functions, compared to children not exposed to cannabis in utero.
Source:Psychiatric TimesMay 15, 2020
“The emergence of COVID-19 has forced health systems to transition rapidly to telehealth, while psychiatric research has ground to a halt,” writes Dr. Ragy Girgis and his co-authors.
- April 27, 2020
Columbia University researchers estimate non-verbal learning disorder may affect up to 3 million children in the United States.
Source:Philadelphia InquirerApril 24, 2020
“We’re using antidepressants more and more to treat both anxiety and depression,” said Dr. Michael Liebowitz.
- March 6, 2020
Dr. Edward V. Nunes will serve as one of the directors of Columbia's Center for Healing of Opioid and Other Substance Use Disorders-Enhancing Intervention, Development and Implementation (CHOSEN).